Literature DB >> 3746495

Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening.

K M Bang, S Tillett, S K Hoar, A Blair, V McDougall.   

Abstract

Fecal Hemoccult testing and flexible sigmoidoscopy have been proposed as means of screening for colorectal cancer in the general population, as well as in identified high-risk groups. A colorectal cancer screening program was conducted for the Pattern Makers' League of North America. A total of 1,473 white males were screened with fecal Hemoccult testing and flexible sigmoidoscopy during the period 1981 to 1983. The fecal Hemoccult test after diet restriction was positive in 38 workers (2.6%). Among 12 colorectal cancers, including in situ cases, only three were positive by this test. The sensitivity of this test for picking up cancer is only 25%. The positive predictive value was 7.9%. It is concluded that the Hemoccult test for the detection of colorectal cancer and polyps is not a valuable tool because of low sensitivity, whereas flexible sigmoidoscopy has a significant role in colorectal cancer screening of an asymptomatic population at risk.

Entities:  

Mesh:

Year:  1986        PMID: 3746495     DOI: 10.1097/00043764-198608000-00033

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  5 in total

1.  Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Authors:  P J Limburg; D A Ahlquist; J A Gilbert; J J Harrington; G G Klee; P C Roche
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Tobacco smoking as a risk factor for colon polyps.

Authors:  S H Zahm; P Cocco; A Blair
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

Review 3.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

Review 4.  Screening for colorectal cancer by immunochemical fecal occult blood testing.

Authors:  H Saito
Journal:  Jpn J Cancer Res       Date:  1996-10

5.  A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study.

Authors:  Stefanie Bünger; Ulrike Haug; Maria Kelly; Nicole Posorski; Katja Klempt-Giessing; Andrew Cartwright; Stephen P Fitzgerald; Vicki Toner; Damien McAleer; Timo Gemoll; Tilman Laubert; Jürgen Büning; Klaus Fellermann; Hans-Peter Bruch; Uwe J Roblick; Hermann Brenner; Ferdinand von Eggeling; Jens K Habermann
Journal:  BMC Cancer       Date:  2012-09-07       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.